Epitope Inc said its board ofdirectors has authorized a three-for-one common stock split forwhich shareholder approval is expected in the next two weeks.    The company announced a two-for-one split last week, butsaid the board reconvened and agreed to change it to athree-for-one split.    Epitope is involved in the production of monoclonalantibodies for diagnostic and therapeutic use in AIDS and otherimmunological diseases. Reuter&#3;